4th Quarter - Report — PFIZER INC. for PFIZER INC. (2019)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

PFIZER INC.

Client

PFIZER INC.

Income

—

Expenses

$2,290,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
4th Quarter - Report (this page)	Jan 21, 2020	$2,290,000	Replaced
4th Quarter - Amendment	Jan 31, 2020	$2,300,000	Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Creates Act Patent Thickets/Hopping

Lobbyist	Covered position, as disclosed
JOSEPH TUCKER KNOTT New	Staff Aide; Chief of Staff
JENNIFER SWENSON WALTON	—

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Natl Economic Council (NEC); State, Dept of (DOS); U.S. Trade Representative (USTR); White House Office; HOUSE OF REPRESENTATIVES; SENATE; Treasury, Dept of; Office of Management & Budget (OMB); Office of the Vice President of the United States; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC)

Trade (domestic/foreign) TRD

U.S.- Japan Trade Negotiations China Trade Negotiations NAFTA/USMCA Foreign Market Access Issues

Lobbyist	Covered position, as disclosed
ELISSA ALBEN	—
STEPHEN CLAEYS New	Trade Counsel, Committee on Ways & Means; Deputy Asst. Secretary for AD/CVD Ops., Dept. of Commerce; Nat'l Security Advisor, Office of the Vice President, White House; Chief of Staff to Assistant Secretary for Import Administration, Dept. of Commerce
EMILY MUELLER	—
ANGELA WALKER RIEMER	—
CATHERINE ROBINSON	—
JENNIFER SWENSON WALTON	—

Contacted: Treasury, Dept of; White House Office; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Natl Economic Council (NEC); Executive Office of the President (EOP); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); State, Dept of (DOS); SENATE; Commerce, Dept of (DOC); Office of the Vice President of the United States

Health Issues HCR

Drug Pricing Biosimilars Drug Shortages Out of Pocket Costs Value Based Arrangements Rebate Reform

Lobbyist	Covered position, as disclosed
PAULA BURG	—
ROBERT JONES	—
JOSEPH TUCKER KNOTT New	Staff Aide; Chief of Staff
EMILY MUELLER	—
ANGELA WALKER RIEMER	—
JENNIFER SWENSON WALTON	—

Contacted: White House Office; Health & Human Services, Dept of (HHS); Office of the Vice President of the United States; Natl Economic Council (NEC); Commerce, Dept of (DOC); Executive Office of the President (EOP); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); SENATE; State, Dept of (DOS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Comprehensive Corporate Tax Reform International Tax Reform OECD Profit Allocation

Lobbyist	Covered position, as disclosed
CAROLINE MOODY SCHELLHAS	—

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Executive Office of the President (EOP); SENATE; Health & Human Services, Dept of (HHS); Treasury, Dept of; Office of the Vice President of the United States; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); State, Dept of (DOS); White House Office

Medicare/Medicaid MMM

Medicare Part D Coverage Gap Rebate Reform Out of Pocket Costs Value Based Arrangements Price Transparency

Lobbyist	Covered position, as disclosed
PAULA BURG	—
EMILY MUELLER	—
ANGELA WALKER RIEMER	—
JENNIFER SWENSON WALTON	—

Contacted: Natl Economic Council (NEC); Executive Office of the President (EOP); Food & Drug Administration (FDA); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); Office of the Vice President of the United States; Centers For Medicare and Medicaid Services (CMS); SENATE; State, Dept of (DOS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; Commerce, Dept of (DOC); Treasury, Dept of

Budget/Appropriations BUD

Health Extenders/Congressional Appropriations

Lobbyist	Covered position, as disclosed
JENNIFER SWENSON WALTON	—

Contacted: State, Dept of (DOS); Executive Office of the President (EOP); Office of the Vice President of the United States; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Commerce, Dept of (DOC); Food & Drug Administration (FDA); SENATE; White House Office; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Natl Economic Council (NEC); Treasury, Dept of

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.